Company Overview

Galephar PR Inc. is an integrated science-driven pharmaceutical company delivering high-quality healthcare products in regulated markets worldwide.

We specialize in R&D of precision-release & targeted oral and pulmonary drug formulations, supported by scalable cGMP manufacturing and product commercialization capabilities, bringing safe and effective therapies to patients.

We focus on complex, value-add products targeting specialty therapeutic areas. Galephar develops propietary pharmaceutical products and complements its pipeline with selected CDMO partnerships supported by strong operational capabilities.

Scientific Expertise

Galephar leverages five decades of pharmaceutical experience to deliver cutting-edge scientific solutions across regulated markets. Our expertise spans API synthesis, precision-release & targeted oral and pulmonary drug formulations, analytical testing, quality control, and end-to-end R&D with seamless integration into scalable drug manufacturing, ensuring that every product is safe, effective, and compliant.

By combining innovative methodologies with deep regulatory knowledge, our team drives the development of both innovative and value-add generic products while maintaining the highest standards of scientific excellence.

This rigorous approach allows us to support our partners throughout the entire product lifecycle, from concept to market, and positions Galephar as a trusted collaborator in advancing healthcare solutions worldwide.